TRPM6 Gene Hypomagnesemia type 1 Genetic Test
Components: TRPM6 Gene Hypomagnesemia type 1 Genetic Test
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Metabolic Disorders
Doctor: General Physician
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for TRPM6 Gene Hypomagnesemia type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with Hypomagnesemia type 1.
Test Details
TRPM6 gene hypomagnesemia type 1 NGS genetic test is a genetic test that examines the TRPM6 gene for mutations or variations that may cause hypomagnesemia type 1. Hypomagnesemia type 1 is a rare genetic disorder characterized by low levels of magnesium in the blood.
The TRPM6 gene provides instructions for making a protein that is involved in the absorption of magnesium from the intestines and its reabsorption in the kidneys. Mutations or variations in this gene can disrupt the normal functioning of the protein, leading to reduced magnesium levels in the body.
The NGS (Next-Generation Sequencing) genetic test is a high-throughput sequencing method that allows for the analysis of multiple genes simultaneously. In the case of TRPM6 gene hypomagnesemia type 1 NGS genetic test, it involves sequencing the TRPM6 gene to identify any mutations or variations that may be associated with the condition.
This genetic test can be used for diagnostic purposes to confirm a suspected case of hypomagnesemia type 1. It can also be used for carrier testing to identify individuals who carry a single copy of the mutated gene but do not show symptoms of the condition. Additionally, this test can be used for prenatal testing to determine if a fetus has inherited the mutated gene.
The results of the TRPM6 gene hypomagnesemia type 1 NGS genetic test can help healthcare providers make informed decisions regarding treatment, management, and genetic counseling for individuals with hypomagnesemia type 1 or those at risk of passing on the condition to their offspring.
Test Name | TRPM6 Gene Hypomagnesemia type 1 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Metabolic Disorders |
Doctor | General Physician |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for TRPM6 Gene Hypomagnesemia type 1 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Hypomagnesemia type 1 |
Test Details |
TRPM6 gene hypomagnesemia type 1 NGS genetic test is a genetic test that examines the TRPM6 gene for mutations or variations that may cause hypomagnesemia type 1. Hypomagnesemia type 1 is a rare genetic disorder characterized by low levels of magnesium in the blood. The TRPM6 gene provides instructions for making a protein that is involved in the absorption of magnesium from the intestines and its reabsorption in the kidneys. Mutations or variations in this gene can disrupt the normal functioning of the protein, leading to reduced magnesium levels in the body. The NGS (Next-Generation Sequencing) genetic test is a high-throughput sequencing method that allows for the analysis of multiple genes simultaneously. In the case of TRPM6 gene hypomagnesemia type 1 NGS genetic test, it involves sequencing the TRPM6 gene to identify any mutations or variations that may be associated with the condition. This genetic test can be used for diagnostic purposes to confirm a suspected case of hypomagnesemia type 1. It can also be used for carrier testing to identify individuals who carry a single copy of the mutated gene but do not show symptoms of the condition. Additionally, this test can be used for prenatal testing to determine if a fetus has inherited the mutated gene. The results of the TRPM6 gene hypomagnesemia type 1 NGS genetic test can help healthcare providers make informed decisions regarding treatment, management, and genetic counseling for individuals with hypomagnesemia type 1 or those at risk of passing on the condition to their offspring. |